...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Cell death biomarkers as early predictors for hepatic dysfunction in patients after orthotopic liver transplantation
【24h】

Cell death biomarkers as early predictors for hepatic dysfunction in patients after orthotopic liver transplantation

机译:细胞死亡生物标志物是原位肝移植术后患者肝功能异常的早期预测指标

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Valid prognostic factors for early identification of a complicated course after orthotopic liver transplantation from deceased donors are rare. The aim of this study was to investigate the prognostic value of different cell death biomarkers and inflammatory markers in patients after orthotopic liver transplantation from deceased donors. METHODS: In total, 100 patients were evaluated for short-term complications within 10 days after orthotopic liver transplantation from deceased donors. Blood samples were collected before surgery, immediately after the end of the surgical procedure, and 1 day and 3, 5, and 7 days later. Plasma levels of total keratin 18, keratin 18 fragments, interleukin 6, tumor necrosis factor α, and soluble intercellular adhesion molecule 1 were measured. RESULTS: Total keratin 18 was demonstrated to be favorable in its prognostic value for early identification of a complicated course in comparison to routine markers of liver impairment (e.g., aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase). In contrast, inflammation markers (e.g., interleukin 6, tumor necrosis factor α and soluble intercellular adhesion molecule 1) were unsuitable for predicting early complications after liver transplantation from deceased donors. CONCLUSIONS: For early identification of patients at high risk for complications, the implementation of total keratin 18 measurements in routine diagnostics after orthotopic liver transplantation from deceased donors should be taken into consideration.
机译:背景:从死者的原位肝移植后,早期鉴定复杂病程的有效预后因素很少。这项研究的目的是调查不同细胞死亡生物标志物和炎症标志物在原发肝移植后原位肝移植患者中的预后价值。方法:总共评估了100例死者原位肝移植后10天内的短期并发症。手术前,手术结束后,以及1天,3天,5天和7天后采集血液样本。测定血浆中的总角蛋白18,角蛋白18片段,白介素6,肿瘤坏死因子α和可溶性细胞间粘附分子1的血浆水平。结果表明,与常规肝损伤标志物(例如天冬氨酸转氨酶,丙氨酸转氨酶,乳酸脱氢酶)相比,总角蛋白18在早期诊断复杂病程方面具有良好的预后价值。相反,炎症标记物(例如白介素6,肿瘤坏死因子α和可溶性细胞间粘附分子1)不适合预测已故供者肝移植后的早期并发症。结论:为了早期发现有并发症高风险的患者,应考虑在死者原位肝移植后常规诊断中采用总角蛋白18测量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号